Indivior PLC (LON:INDV - Get Free Report)'s share price was up 11.1% during trading on Friday . The stock traded as high as GBX 799 ($10.73) and last traded at GBX 772 ($10.37). Approximately 551,238 shares were traded during trading, a decline of 49% from the average daily volume of 1,087,031 shares. The stock had previously closed at GBX 695 ($9.34).
Indivior Trading Up 6.0 %
The stock's fifty day moving average price is GBX 722.71 and its 200 day moving average price is GBX 803.01. The stock has a market cap of £1.35 billion, a P/E ratio of -716.80, a PEG ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Recommended Stories
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
